Eric is a co‑founder of the French Myeloma Patients Association (AF3M), where he first became involved as a caregiver for his late father in 2007. He currently serves as Board Member and Head of International Relations. Eric brings over 40 years of experience in the financial sector, having led asset‑management sales across several European regions. He is committed to fostering the sharing of best practices among patient organisations and strengthening their collective efforts to serve the wider European myeloma community. Eric completed the MPE Advocate Development Programme, the WECAN Academy in 2025 and is a EUPATI HTA Ambassador.
Israel Amyloidosis Association highlights innovation and patient support at annual conference
The Israel Amyloidosis Association held its annual conference on 23 October 2026, bringing together approximately 200 patients, clinicians and researchers from across Israel. The event took place just ahead of…




